119.37 USD
+3.00
2.58%
At close Updated Mar 25, 4:00 PM EDT
Pre-market
After hours
119.72
+0.35
0.29%
1 day
2.58%
5 days
4.11%
1 month
-2.52%
3 months
11.79%
6 months
53.83%
Year to date
12.14%
1 year
35.85%
5 years
64.44%
10 years
136.8%
 

About: Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).

Employees: 75,000

0
Funds holding %
of 8,092 funds
0
Analysts bullish %
of 8 analysts
0
Positive news %
of 53 articles
Price charts implemented using Lightweight Charts™